"Oral Ozempic Breakthrough: Groundbreaking Pill Delivers Major Weight Loss Without Injections"
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
"Oral Ozempic Breakthrough: Groundbreaking Pill Delivers Major Weight Loss Without Injections"
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Discover the latest groundbreaking developments in GLP-1 medications as our podcast examines the game-changing OASIS-4 clinical trial results published in The New England Journal of Medicine. This episode explores how the new oral form of semaglutide achieved impressive 14-16% weight loss results, rivaling injectable versions like Ozempic and Wegovy. We also cover surprising new research revealing the pancreas's natural GLP-1 production abilities, upcoming patent expirations that could dramatically reduce medication costs, and emerging evidence that semaglutide may protect against diabetic eye disease. Stay informed about regulatory changes affecting compounded versions and learn what these advancements mean for obesity treatment, metabolic health, and diabetes management. Perfect for healthcare providers, patients, and anyone interested in the evolving landscape of weight management medications.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI
Pas encore de commentaire